Form D · Biotechnology
Vektor Medical, Inc.
San Diego, CA · CIK 0001732150
Offering snapshot reported Feb 20, 2024 · SEC filing
- Reported sold
- $28.9M Offering amount: $37.5M
- Investors reported
- 98 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 2, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 20, 2024 | Initial | $28,898,880 | No comparison | 98 | SEC filing |
| Nov 15, 2019 | Initial | $3,598,976 | No comparison | 22 | SEC filing |
| Jul 26, 2018 | Initial | $11,310 | No comparison | 1 | SEC filing |
| May 11, 2018 | Initial | $12,150 | No comparison | 1 | SEC filing |
| Feb 27, 2018 | Initial | $370,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505570
Source: Form D, filed Feb 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| C. David Adair | Director |
| Joe Braidwood | Executive |
| Lana Caron | Executive |
| Douglas S. Komen | Executive |
| Robert J. Krummen | Director, Executive |
| Luc Marengere | Director |
| Kalle Marsal | Director |
| Alexander M. Monko | Director, Executive |
| Shannon St. Clair | Executive |
| Chris Villongco | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9255 Towne Centre Drive Suite 750
San Diego, CA, 92121
San Diego, CA, 92121